PerkinElmer (PKI) Tops Q4 EPS by 3c, Offers FY18 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017
January 25, 2018 4:15 PM ESTFourth Quarter 2017 GAAP revenue growth of 13% to $642 million; 6% organic revenue growth excluding EUROIMMUN Fourth Quarter 2017 GAAP losses per share from continuing operations of $0.35; Adjusted earnings per share of $0.97, an increase of 17% Completes EUROIMMUN acquisition Initiates FY 2018 GAAP earnings per share guidance of $2.28 from continuing operations; Adjusted EPS guidance of $3.50, an increase of 21%
WALTHAM, Mass.--(BUSINESS WIRE)--... More
